CNC.NYSECentene CORP

Form 4: Centene CFO Asher Sells Shares for Tax Obligations

Sentiment:

Insider Transaction Report


Centene's Chief Financial Officer, Andrew Lynn Asher, reported the disposition of 15,241 shares of common stock to cover tax obligations related to restricted stock unit vesting.

Summary

  • Andrew Lynn Asher, Chief Financial Officer of Centene Corp (CNC), reported a transaction on March 15, 2026.
  • 15,241 shares of common stock were disposed of at a price of $34.45 per share.
  • This disposition was due to shares being withheld for taxes upon the vesting of previously granted restricted stock units.
  • Following this transaction, Asher beneficially owns 747,989.48 shares of common stock.
  • This ownership includes 448,650 shares of previously granted restricted stock units and performance stock units, which are subject to vesting requirements.
  • Asher also holds 13,449 common stock options with an exercise price of $81.85, expiring on December 15, 2031.
  • These performance stock options, granted on December 15, 2021, become exercisable if CNC's common stock closing price reaches or exceeds $100 per share for 20 consecutive trading days following the grant date.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a neutral to slightly positive filing. The transaction is routine for tax purposes, and the CFO retains significant equity, including performance-based options, aligning interests with shareholders.

Positives

  • The transaction is a routine tax-related disposition, not a discretionary sale by the CFO, indicating no change in management's confidence.
  • Significant remaining beneficial ownership of 747,989.48 shares by the CFO, including a large portion of unvested equity, aligns management's interests with shareholders.
  • The existence of performance stock options with a $100 per share trigger indicates a potential upside target for the stock price, incentivizing management to drive value.

Negatives

  • A disposition of 15,241 shares, even for tax purposes, reduces the CFO's direct equity holdings.

Risks

  • The performance stock options are subject to a specific stock price condition ($100 per share for 20 consecutive trading days) which may not be met, potentially rendering the options worthless.
  • A significant portion of the CFO's beneficial ownership (448,650 shares) is still subject to vesting requirements, meaning it is not fully owned yet and could be forfeited under certain conditions.

Future Outlook

The filing does not provide explicit forward-looking statements or guidance beyond the conditions for the performance stock options to become exercisable, which implies a potential future stock price target of $100 per share for 20 consecutive trading days.

Industry Context

StockSavvy.ai notes that routine Form 4 filings for tax-related dispositions are common for executives receiving equity compensation. This particular filing indicates Centene's continued use of performance-based equity awards to incentivize management, a practice prevalent across the healthcare and managed care industry to align executive compensation with shareholder value creation.

Comparison to Industry Standards

  • This transaction is a standard practice for executives in publicly traded companies, particularly in the healthcare sector, where equity compensation is a significant component of remuneration.
  • Companies like UnitedHealth Group (UNH) and Elevance Health (ELV) also utilize similar equity compensation structures, leading to comparable tax-related share dispositions by their executives upon vesting.
  • The performance-based options with a $100 trigger are a specific incentive mechanism, common in growth-oriented companies, aiming to drive stock appreciation and align executive performance with shareholder returns.

Stakeholder Impact

  • Shareholders: The CFO's continued significant equity holding, including performance-based options, suggests alignment with shareholder interests for stock appreciation. The tax-related sale is a minor, non-discretionary event.
  • Management: The transaction reflects the realization of previously granted equity compensation, while a substantial portion remains unvested, providing ongoing incentive.

Key Dates

DateDescription
2021-12-15Grant date of Performance Stock Option.
2026-03-15Date of common stock disposition for tax withholding.
2026-03-17Signature date of the filing.
2031-12-15Expiration date of Common Stock Option.

Recommendation

hold

This Form 4 filing details a routine, non-discretionary sale of shares by the CFO for tax purposes upon the vesting of restricted stock units. It does not indicate any change in the company's fundamentals or strategic direction. The CFO retains a substantial equity stake, including performance-based options, which aligns management's interests with long-term shareholder value. Therefore, a "hold" recommendation is appropriate as this filing provides no new information to alter an existing investment thesis.

Keywords

Centene Corp, CNC, Form 4, Insider Transaction, Andrew Lynn Asher, CFO, Stock Options, Restricted Stock Units, Tax Withholding, Beneficial Ownership

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.